MedPath
HSA Approval

PORO Suppository 250mg

SIN13754P

PORO Suppository 250mg

PORO Suppository 250mg

January 19, 2010

YUNG SHIN PHARMACEUTICAL (SINGAPORE) PTE LTD

YUNG SHIN PHARMACEUTICAL (SINGAPORE) PTE LTD

Regulatory Information

HSA regulatory responsibility and product classification details

Regulatory Responsibility

RegistrantYUNG SHIN PHARMACEUTICAL (SINGAPORE) PTE LTD
Licence HolderYUNG SHIN PHARMACEUTICAL (SINGAPORE) PTE LTD

Product Classification

D
Drug Type
Therapeutic
F
Forensic Class
General Sale List
HSA Singapore Classification

Formulation Information

SUPPOSITORY

RECTAL

Medical Information

N02BE01

paracetamol

Manufacturer Information

YUNG SHIN PHARMACEUTICAL (SINGAPORE) PTE LTD

Y.S.P. INDUSTRIES (M) SDN. BHD.

Active Ingredients

Paracetamol (Acetaminophen)

250mg

Acetaminophen

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

PORO Suppository 250mg - HSA Approval | MedPath